Ciaffoni Joseph
CIK 0001443841
President and CEODirector
Filings
10
Latest Feb 12, 2026
Issuers covered
2
Showing
10 of 10
Page 1
Track record
12 of 12 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 50% | -3.2% | -4.6% | +12.2% | -10.6% |
| 90 days | 12 | 25% | -9.3% | -8.1% | +15.6% | -31.7% |
| 180 days | 12 | 25% | -7.6% | -6.6% | +13.1% | -18.6% |
| 365 days | 12 | 8% | -29.8% | -44.7% | +2.5% | -52.3% |
Issuers
Companies where Ciaffoni Joseph has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| COLL | Collegium Pharmaceutical, Inc | 9 | Feb 14, 2024 |
| INDV | Indivior Pharmaceuticals, Inc. | 1 | Feb 12, 2026 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|